Author(s): Amante, Sofia Martins
Date: 2014
Persistent ID: http://hdl.handle.net/10451/24565
Origin: Repositório da Universidade de Lisboa
Subject(s): Diabetes gestacional; Diabetes mellitus; Obstetrícia
Author(s): Amante, Sofia Martins
Date: 2014
Persistent ID: http://hdl.handle.net/10451/24565
Origin: Repositório da Universidade de Lisboa
Subject(s): Diabetes gestacional; Diabetes mellitus; Obstetrícia
Diabetes mellitus (DM) is a metabolic disorder characterized by glucose intolerance, which complicates about 18% of pregnancies. In 90% of cases, this condition is detected or begins during pregnancy, being classified as gestational diabetes (DG). In the remaining 10% of cases, DM already existed before pregnancy (pre-gestational diabetes mellitus (DMP) - type 1 diabetes mellitus (DM1) or type 2 diabetes mellitus (DM2)), which predisposes both the pregnant woman and the fetus to complications related to this disease. Currently, there is consistent literature documenting an increase in maternal and fetal adverse effects in pregnant women with DM (DMP or DG) compared to pregnant women without pathology, which makes it essential to achieve adequate metabolic control by implementing dietary changes, lifestyle or the institution of pharmacological therapy. In pathophysiological and clinical terms it is easy to understand that DMP leads to more obstetric complications when compared to DG, however, there are few studies that objectively compare these two groups.